Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Hepatology (Baltimore, Md.)|April 5, 2013
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levelsMilan J Sonneveld, Bettina E Hansen, Teerha Piratvisuth, et al.
Pharmacoeconomics|March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis CJens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D studyMarianne Martinello, Sanjay Bhagani, David Shaw, et al.
Liver Cancer|May 17, 2024
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Peter R Galle, Yee Chao, et al.
Digestive Diseases and Sciences|September 3, 2014
Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis BNaoky C Tsai, Patrick Marcellin, Maria Buti, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesisDarrell H G Crawford, Linda M Fletcher, Stefan G Hubscher, et al.
Digestive Diseases and Sciences|December 24, 2014
Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infectionMaria Buti, Naoky Tsai, Joerg Petersen, et al.
The Journal of Infectious Diseases|November 26, 2015
L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B SubstitutionsEvguenia S Svarovskaia, Edward Gane, Hadas Dvory-Sobol, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 2019
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New ZealandLuis Calzadilla-Bertot, Gary P Jeffrey, Bryon Jacques, et al.
Antiviral Therapy|April 29, 2022
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adultsEdward Gane, Mina Pastagia, Ullrich Schwertschlag, et al.
Pageof 13